The latest closing stock price for Corvus Pharmaceuticals as of November 22, 2024 is 8.95.
An investor who bought $1,000 worth of Corvus Pharmaceuticals stock at the IPO in 2016 would have $-372 today, roughly 0 times their original investment - a -5.04% compound annual growth rate over 9 years.
The all-time high Corvus Pharmaceuticals stock closing price was 21.37 on March 27, 2017.
The Corvus Pharmaceuticals 52-week high stock price is 10.00, which is 11.7% above the current share price.
The Corvus Pharmaceuticals 52-week low stock price is 1.30, which is 85.5% below the current share price.
The average Corvus Pharmaceuticals stock price for the last 52 weeks is 3.25.
An investor who bought $1,000 worth of Corvus Pharmaceuticals stock at the IPO in 2016 would have $-372 today, roughly 0 times their original investment - a -5.04% compound annual growth rate over 9 years.
The all-time high Corvus Pharmaceuticals stock closing price was 21.37 on March 27, 2017.
The Corvus Pharmaceuticals 52-week high stock price is 10.00, which is 11.7% above the current share price.
The Corvus Pharmaceuticals 52-week low stock price is 1.30, which is 85.5% below the current share price.
The average Corvus Pharmaceuticals stock price for the last 52 weeks is 3.25.